Homepage
Medication Guide
Dosage and Administration, Recommended Dosage of Avelumab (Bavencio)
Avelumab (Bavencio) is a programmed death-ligand 1 (PD-L1)-blocking monoclonal antibody approved for the treatment of various solid tumors.Dosage and Administration, Recommended Dosage of Avelumab (Ba...
503
Wednesday, November 26th, 2025, 11:37
What are the Indications of Avelumab (Bavencio)?
Avelumab (Bavencio) is an innovative programmed death-ligand 1 (PD-L1) blocking antibody that activates the human immune system to combat tumor cells. As a key representative of immune checkpoint inhi...
506
Wednesday, November 26th, 2025, 11:34
What are the Procurement Channels for Avelumab (Bavencio)?
Avelumab (Bavencio) is a humanized monoclonal antibody targeting PD-L1, approved globally for the treatment of solid tumors including metastatic Merkel cell carcinoma, locally advanced or metastatic u...
509
Wednesday, November 26th, 2025, 11:01
Side Effects of Relugolix (Orgovyx)
Relugolix (Orgovyx) is an oral gonadotropin-releasing hormone receptor antagonist indicated for the treatment of advanced prostate cancer. As a novel endocrine therapy, it exhibits significant efficac...
505
Wednesday, November 26th, 2025, 10:55
What are the Precautions for Using Relugolix (Orgovyx)?
Relugolix (Orgovyx) is a next-generation gonadotropin-releasing hormone receptor antagonist that provides an important treatment option for patients with advanced prostate cancer. As an orally adminis...
508
Wednesday, November 26th, 2025, 10:50
Dosage and Administration, Recommended Dosage of Relugolix (Orgovyx)
Relugolix (Orgovyx) is an oral gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer. As a novel endocrine therapy, its ...
505
Wednesday, November 26th, 2025, 10:47
What are the Indications of Relugolix (Orgovyx)?
Relugolix (Orgovyx) is a novel gonadotropin-releasing hormone (GnRH) receptor antagonist that was approved in the United States in 2020 for the treatment of prostate cancer.What are the Indications of...
506
Wednesday, November 26th, 2025, 10:44
What are the Procurement Channels for Derabrutinib (Datroway)?
Derabrutinib (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC) indicated for the treatment of adult patients with unresectable or metastatic HR-positive, HER2-negative breast cancer who ha...
503
Wednesday, November 26th, 2025, 09:15
How to Use Ziihera (Zanidatamab-hrii)
Ziihera (zanidatamab-hrii) is an innovative bispecific HER2-targeted antibody drug that provides a new treatment option for patients with HER2-positive biliary tract cancer. Its standard usage methods...
503
Tuesday, November 25th, 2025, 11:23
What Is Ziihera (Zanidatamab-hrii)?
Ziihera (zanidatamab-hrii) is a novel targeted therapy granted accelerated approval by the U.S. FDA, specifically indicated for the treatment of certain types of biliary tract cancers. As a significan...
508
Tuesday, November 25th, 2025, 11:20
37 / 200
1994 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved